Assessing the economic burden of Alzheimer’s disease patients first diagnosed by specialists
Crossref DOI link: https://doi.org/10.1186/s12877-016-0303-5
Published Online: 2016-07-11
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kirson, Noam Y.
Desai, Urvi
Ristovska, Ljubica
Cummings, Alice Kate G.
Birnbaum, Howard G.
Ye, Wenyu
Andrews, J. Scott
Ball, Daniel
Kahle-Wrobleski, Kristin
Funding for this research was provided by:
Eli Lilly and Company (US)